Search

Your search keyword '"Rascol, Olivier"' showing total 1,526 results

Search Constraints

Start Over You searched for: Author "Rascol, Olivier" Remove constraint Author: "Rascol, Olivier"
1,526 results on '"Rascol, Olivier"'

Search Results

1. Amantadine use in the French prospective NS-Park cohort

2. The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson’s disease patients: a prospective study

3. Prognosis of impulse control disorders in Parkinson’s disease: a prospective controlled study

4. Patient-perceived progression in multiple system atrophy: natural history of quality of life

6. Volumetric changes and clinical trajectories in Parkinson’s disease: a prospective multicentric study

7. Describing complex disease progression using joint latent class models for multivariate longitudinal markers and clinical endpoints

8. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

9. Joint models for the longitudinal analysis of measurement scales in the presence of informative dropout

10. Parkinsonian central pain is linked to the connectivity of the nucleus accumbens and the anterior insula

12. Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial

13. Skull Density Ratio as Arm‐Allocation Parameter for a Controlled Focused Ultrasound Trial in Parkinson's Disease

19. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

20. Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)

21. Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial

23. Personality assessment with Temperament and Character Inventory in Parkinson's disease

24. Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies

25. Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease

26. How has the future investment program stimulated research and innovation in health?

27. Comment le programme d’investissements d’avenir a-t-il stimulé la recherche et l’innovation en santé ?

28. Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease.

30. Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting

32. A Double‐Blind, Randomized, Placebo‐Controlled Trial of Bumetanide in Parkinson's Disease

33. Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study

35. A genome-wide association study in multiple system atrophy

43. Trial of Deferiprone in Parkinson’s Disease

45. PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability

47. Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?

49. Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial

Catalog

Books, media, physical & digital resources